Victory Capital Management Trims Boston Scientific Stake

Institutional investor reduces holdings in medical device company by 38.7%

Published on Mar. 8, 2026

Got story updates? Submit your updates here. ›

Victory Capital Management Inc. has reduced its position in Boston Scientific Corporation (NYSE:BSX) by 38.7% in the third quarter, according to a recent SEC filing. The firm now owns 483,268 shares of the medical equipment provider's stock, down from 788,478 shares previously.

Why it matters

Boston Scientific is a major medical device company, so changes in institutional ownership of its stock can provide insights into market sentiment and expectations around the company's performance. Victory Capital's reduced stake may signal concerns about Boston Scientific's outlook or a shift in the firm's investment strategy.

The details

According to the filing, Victory Capital Management sold 305,210 shares of Boston Scientific during the third quarter. The firm's remaining holdings in the company were valued at $47,181,000 as of the end of the quarter.

  • Victory Capital Management filed the 13F report disclosing the stake reduction on March 8, 2026.

The players

Victory Capital Management Inc.

An investment management firm that provides a range of investment strategies and services to institutional and individual investors.

Boston Scientific Corporation

A global medical device company that develops, manufactures and markets a broad portfolio of products used in less-invasive medical procedures.

Got photos? Submit your photos here. ›

The takeaway

The reduction in Victory Capital's Boston Scientific holdings could signal broader concerns about the medical device industry or the company's specific outlook. Investors will likely watch for any further changes in institutional ownership of Boston Scientific stock in the coming quarters.